Cystic Fibrosis and Salt Therapy: Scientific Background and Practical Application

What is cystic fibrosis?

Cystic fibrosis (also called mucoviscidosis) is an inherited metabolic disorder that primarily affects the respiratory and digestive systems. The disease is caused by mutations in the CFTR gene, which encodes a chloride channel protein on the surface of cells.

Under normal circumstances this channel regulates the movement of salt and water across cells. In CF the channel does not work properly: chloride cannot exit the cells, while sodium and water are overly reabsorbed. The result is extremely thick, sticky secretions that clog the airways, the digestive tract and other organs.

Think of it like a plumbing system. Normally water flows freely through pipes and flushes debris away. In CF the “water” becomes thick, sticky syrup that clogs the pipes. This “blockage" causes the symptoms of the disease.

Cystic fibrosis affects roughly 2,500–3,000 people in Hungary. In terms of frequency it is one of the most common severe inherited disorders: one in about 25 people is a carrier of a mutant gene, but the disease only develops if a child inherits the faulty gene from both parents.

CF symptoms and complications

Cystic fibrosis affects multiple organs, but the most serious consequences occur in the respiratory system.

Respiratory symptoms include a persistent productive cough with thick, often greenish-yellow sputum. Recurrent respiratory infections — pneumonia and bronchitis — are common because stagnant secretions provide an ideal environment for bacteria. Shortness of breath and reduced exercise tolerance worsen as the disease progresses. Over time bronchiectasis (permanent dilation and damage of the bronchi) develops.

Digestive symptoms include pancreatic insufficiency, which leads to malabsorption, fatty stools and malnutrition. Intestinal obstruction (notably meconium ileus in newborns), liver disease and diabetes are also common complications.

The paranasal sinuses can also be involved: chronic sinusitis and nasal polyps are frequent in CF.

Fundamentals of cystic fibrosis treatment

Treating cystic fibrosis is complex and rests on multiple pillars. It is important to understand this background because salt therapy is meaningful only in this context — as a supplement, not as a standalone treatment.

The first pillar is mobilization of airway secretions. This includes respiratory physiotherapy and chest physiotherapy, which should be performed several times daily. Mucolytic medications — such as dornase alfa (Pulmozyme) and hypertonic saline — thin secretions and help remove them by coughing.

The second pillar is treatment and prevention of infections. Inhaled antibiotics (tobramycin, colistin) deliver the active agent directly to the airways. Regular sputum culture testing helps monitor the bacterial flora.

The third pillar is optimizing nutrition. Pancreatic enzyme replacement is essential for adequate nutrient absorption. A high-calorie diet and vitamin supplementation help maintain body weight.

The fourth pillar is CFTR modulators — the new generation of drugs such as ivacaftor/lumacaftor (Orkambi) or elexacaftor/tezacaftor/ivacaftor (Trikafta). These drugs target the defective protein itself and can dramatically improve symptoms for certain mutations. Unfortunately they are not suitable for every patient, and availability in Hungary is limited.

What is salt therapy and how does it work in CF?

Salt therapy — more scientifically, inhalation of hypertonic saline — is one of the most important adjunctive methods in CF treatment. But before diving into details, let’s clarify the differences between the various forms of salt therapy.

In medical practice hypertonic saline (3–7% NaCl solution) is nebulized into the airways, typically using a compressor nebulizer. This method is well standardized and most clinical trials used this approach.

Halotherapy (dry salt therapy) takes place in salt rooms or with a halogenerator that generates dry salt particles for inhalation. This is less standardized but has also been studied in CF.

Home salt therapy devices — such as the SaltDome — produce a wet salt aerosol using ultrasonic nebulization. These devices operate on a similar principle to inhaling hypertonic saline.

The mechanism of salt therapy in CF is well understood. Salt particles reaching the airways exert an osmotic effect: they draw water from the airway mucosa. This dilutes the thick, sticky secretions characteristic of CF.¹ Imagine diluting thick, sticky honey with water — it flows more easily and is easier to cough up.

The second effect is improved mucociliary clearance. The airways are lined with tiny cilia that rhythmically sweep mucus out. In CF these cilia are trapped in the thick secretions. Salt therapy–thinned secretions are easier to move, so the cilia can work more effectively.²

The third effect is reduction of inflammation. Although the exact mechanism is not fully clear, some studies suggest hypertonic saline also has anti-inflammatory effects in the airways.³

What do the scientific studies say?

Inhalation of hypertonic saline in CF is one of the most researched adjunctive therapies. Below I summarize the most important studies.

The 2006 New England Journal of Medicine trial is one of the landmark studies in this field.⁴ Elkins and colleagues followed 164 clinically stable CF patients for 48 weeks in a double-blind, randomized, controlled trial. Patients inhaled 4 ml of 7% hypertonic saline twice daily or 0.9% isotonic saline (placebo).

The results were convincing: the hypertonic saline group had statistically significant improvements in FVC (forced vital capacity, +82 ml) and FEV1 (forced expiratory volume in one second, +68 ml). More importantly: pulmonary exacerbations (acute respiratory worsenings) decreased by 56%! Seventy-six percent of patients receiving hypertonic saline remained exacerbation-free versus 62% in the control group. The authors concluded that hypertonic saline is an “inexpensive, safe and effective adjunctive therapy for patients with cystic fibrosis."

The 2023 Cochrane meta-analysis pooled 17 randomized trials with 966 participants (from 4-month-old infants to 63-year-old adults).⁵ The conclusions were that regular use of hypertonic saline reduces the frequency of pulmonary exacerbations, improves lung function after 4 weeks, complements respiratory physiotherapy well, and is generally well tolerated.

The 2019 PRESIS trial investigated the youngest age group: infants under 4 months.⁶ Stahl and colleagues followed 42 infants with CF for 52 weeks. The group that received 6% hypertonic saline showed better outcomes in lung function measures (LCI – lung clearance index) and weight gain. The trial demonstrated that early initiation can be safe and beneficial.

The 2012 ISIS trial studied 321 infants and young children (4–60 months) over 48 weeks.⁷ While no significant difference in the number of pulmonary exacerbations was found in this age group, the treatment proved to be safe.

The 2015 halotherapy pilot study specifically examined the effect of dry salt therapy in CF patients.⁸ Al Achkar and colleagues found that halotherapy improved paranasal sinus symptoms in CF and recommended further study as an adjunctive treatment.

Effects of salt therapy on CF symptoms

In practice CF patients report the following effects with regular salt therapy.

Easier sputum clearance is the most frequently cited benefit. Thinner secretions are easier to cough up, which also makes respiratory physiotherapy more effective. Many report that salt therapy before morning physiotherapy results in much more productive coughing.

Fewer respiratory exacerbations are crucial in CF because each exacerbation — every acute worsening, hospitalization, or course of IV antibiotics — further damages the lungs. The NEJM trial’s 56% reduction is a major difference for quality of life and long-term prognosis.

Improved lung function is also an important outcome. Although the magnitude of improvement is modest (FEV1 improved on average by 68 ml in the NEJM trial), in CF every percentage point of lung function matters.

Clearing the paranasal sinuses is an additional benefit, since chronic sinusitis is very common in CF and significantly impairs quality of life.

Different salt therapy methods in CF

Several salt therapy methods can be used in CF, and it is important to know their advantages and disadvantages.

Medical hypertonic saline inhalation (3–7% NaCl) is the most studied and standardized method. It is performed with a compressor nebulizer, typically 1–2 times daily, 4 ml per session. Its advantage is precise dosing and reproducibility. Its drawback is that it is time-consuming (15–20 minutes per session), and cleaning the device is important to prevent infections.

Halotherapy (salt room) is less standardized, but the 2015 pilot study showed promising results, particularly for sinus symptoms.⁸ An advantage is the pleasant, relaxing experience. A disadvantage is that regular visits may be a logistical challenge for CF patients.

Home salt therapy devices — such as the SaltDome — generate salt aerosol by ultrasonic nebulization. According to Semmelweis University, salt particles between 0.5 and 5 microns can reach the lower airways.⁹ Their advantage is home use: they can be used at night while sleeping, so they do not add to daytime treatment burden.

Home salt therapy in CF: practical considerations

If you are a CF patient or a parent of a child with CF considering home salt therapy, keep a few practical points in mind.

The SaltDome devices may be particularly practical for nighttime use. The daily treatment burden in CF is huge: respiratory physiotherapy, inhalations, medications — these can take hours each day. Nighttime salt therapy does not require extra daytime time.

The device can be placed in the bedroom and while you sleep (or your child sleeps) it continuously produces salty air. This can be especially useful if you want to facilitate morning sputum clearance.

Important: SaltDome devices do not replace medically prescribed hypertonic saline inhalation! If your doctor has prescribed 3–7% saline with a nebulizer, continue that treatment. A home device is a supplement that can provide salt therapy effects outside of scheduled treatments.

The place of salt therapy in CF management

Let me emphasize again: salt therapy is an adjunctive treatment in CF. It does not replace respiratory physiotherapy, antibiotics, dornase alfa, CFTR modulators or any other physician-prescribed therapy.

The Cochrane review also highlights that hypertonic saline is “a good adjunct to chest physiotherapy."⁵ It is most effective when used as part of a comprehensive treatment protocol.

Think of CF treatment like an orchestra. Each instrument has its role: respiratory physiotherapy is the rhythm section, antibiotics are the bass guitar, CFTR modulators are the lead guitar. Salt therapy can be the backing vocal that enriches the overall sound — but it cannot produce the full orchestral performance alone.

Benefits of salt therapy in CF: inexpensive (especially with home devices), safe (the NEJM study found no serious adverse events), easy to integrate into daily routine, and it can improve sputum clearance and lung function.

Before you start treatment

As a CF patient or parent of a child with CF, always consult your CF center physician before beginning any new treatment — including salt therapy. There are several reasons for this.

The first is drug interaction and treatment sequencing. There is a recommended order for inhalation therapies relative to other inhaled treatments (hypertonic saline is usually recommended before dornase alfa or before respiratory physiotherapy). Your physician can help integrate home salt therapy into your existing protocol.

The second is infection control. Preventing airway infections is critical in CF. Regular cleaning of home devices is essential — your physician or CF nurse can advise you on an appropriate hygiene protocol.

The third is individual variability. Not every CF patient responds the same way to salt therapy. Some patients may experience bronchospasm with hypertonic saline — therefore it is recommended to try the first session under medical supervision.

The fourth point is that CF care is continuously evolving. Your physician is up to date with the latest recommendations and research and can advise you on what is best for you at a given time.

Possible side effects and precautions

Inhalation of hypertonic saline is generally well tolerated, but there are a few possible side effects to be aware of.

Coughing is the most common side effect, but this is often a desirable response — it indicates mobilization of secretions. However, if coughing is too intense or uncomfortable, you can reduce the concentration (for example to 3% instead of 7%) or shorten the inhalation time.

Bronchospasm can occur, especially in more sensitive patients. That is why it is recommended to try the treatment for the first time under medical supervision. Pre-treatment with a bronchodilator (salbutamol) can reduce this risk — in the NEJM trial every patient received a bronchodilator before saline.⁴

Mild throat irritation and a salty taste are common transient discomforts.

A 2021 Italian review found that hypertonic saline combined with hyaluronic acid (HS+HA) is better tolerated, particularly in those sensitive to pure hypertonic saline.¹⁰ This combination is also available as a pharmacy product in Hungary.

Practical tips for CF patients

If you start home salt therapy alongside CF treatment, here are some practical tips.

Integrate it into your existing routine. Nighttime use requires no extra daytime time and can help with morning sputum clearance. If you prefer daytime use, try to schedule it before respiratory physiotherapy.

Keep the device clean. Preventing infections is critical in CF. Follow the manufacturer's instructions for device cleaning and use distilled or sterile water to prepare saline solutions where recommended.

Listen to your body. If you cough more easily and produce more sputum after treatment, that is a good sign. If you experience shortness of breath, chest tightness or wheezing, stop the treatment and contact your physician.

Keep a treatment diary. Record when you use the device, what effects you notice and how your condition changes. This helps you and your physician evaluate the impact of salt therapy.

Combine it with respiratory physiotherapy. Salt therapy mobilizes secretions, while coughing and physiotherapy help remove them. Together they are more effective than either alone.

Summary – Quick overview

What is this article? A comprehensive guide on cystic fibrosis (CF, mucoviscidosis) and salt therapy (inhaled hypertonic saline, halotherapy) presenting the scientific background, NEJM and Cochrane study results, and options for home use.

Who is it for? Children and adults with cystic fibrosis, their parents and relatives, CF center professionals, and anyone looking for adjunctive treatment options in CF.

Main message: Inhalation of hypertonic saline is a recognized, scientifically supported adjunctive treatment in CF. The NEJM trial demonstrated a 56% reduction in pulmonary exacerbations and improved lung function. Salt therapy does not replace core CF treatments (respiratory physiotherapy, antibiotics, dornase alfa, CFTR modulators) but can effectively complement them. Home salt therapy devices offer additional options to increase daily salt exposure.

Key concepts and definitions:

Mechanism of action in CF:

Salt therapy acts via three main mechanisms in cystic fibrosis. First is osmotic secretion dilution: hypertonic saline draws water from the airway mucosa, diluting the thick secretions characteristic of CF. Second is improved mucociliary clearance: thinner secretions are more easily moved by the cilia. Third is anti-inflammatory effects: some studies suggest hypertonic saline reduces airway inflammation.

Summary of scientific evidence:

Evidence level: High. Inhaled hypertonic saline in CF is supported by several large randomized controlled trials and a Cochrane meta-analysis as an adjunctive therapy.

Contraindications and precautions:

Relative contraindications to salt therapy in CF include a strong tendency for bronchospasm and acute pulmonary exacerbation (in which case antibiotic treatment is primary). Always consult your CF center physician before starting treatment. The first session is recommended under medical supervision. Pre-treatment with a bronchodilator may reduce the risk of bronchospasm.

Frequently asked questions:

Can salt therapy replace CF medication? No. Salt therapy is an adjunctive method that can be used alongside respiratory physiotherapy, antibiotics, dornase alfa and CFTR modulators. Never discontinue prescribed treatments in favor of salt therapy.

How long until I notice a meaningful effect? The NEJM trial detected lung function improvement as early as 4 weeks. Achieving the full benefit requires regular, long-term use.

Is salt therapy safe for children with CF? Yes. The PRESIS and ISIS trials included infants and young children and found it to be safe. Always consult your child’s CF physician before starting treatment.

What concentration of saline should I use? Most clinical trials used 7% hypertonic saline. If you are sensitive, you can start with a lower concentration (3%). Home devices typically produce aerosols with lower effective concentrations.

When should I use salt therapy in my daily routine? Hypertonic saline inhalation is generally recommended before respiratory physiotherapy or before dornase alfa. Home devices can be used at night. Consult your physician about optimal timing.

Can salt therapy cause bronchospasm? Yes, particularly in sensitive patients. That is why it is recommended to try the first session under medical supervision and to consider bronchodilator pre-treatment.

Detailed guides by condition

If a specific disease or condition interests you, read our detailed guides where we present salt therapy options supported by scientific studies:

• Sinusitis and salt therapy – Get rid of sinusitis
• Asthma and salt therapy – Natural breathing support
• COPD and salt therapy – Easier breathing, better quality of life
• Common cold and salt therapy – Faster recovery
• Hay fever and salt therapy – Relief for allergic symptoms
• Post-pneumonia recovery – Salt therapy as an adjunct
• Snoring and salt therapy – How it can help clear breathing
• Dermatological conditions and salt therapy – Adjunct for eczema and psoriasis

References

1. Robinson M, et al. (1997). Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax, 52(10):900-903. PMC free article
2. Donaldson SH, et al. (2006). Mucus clearance and lung function in cystic fibrosis with hypertonic saline. New England Journal of Medicine, 354(3):241-250.
3. Brivio A, et al. (2016). Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 29(6):482-489. PubMed: 27149365
4. Elkins MR, et al. (2006). A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis. New England Journal of Medicine, 354(3):229-240. PubMed: 16421364
5. Wark P, McDonald VM, Smith S. (2023). Nebulised hypertonic saline for cystic fibrosis. Cochrane Database of Systematic Reviews, 6(6):CD001506. PubMed: 37319354
6. Stahl M, et al. (2019). Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study. American Journal of Respiratory and Critical Care Medicine, 199(10):1238-1248. PubMed: 30409023
7. Rosenfeld M, et al. (2012). Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA, 307(21):2269-2277. PubMed: 22610452
8. Al Achkar M, et al. (2015). Halotherapy in Patients with Cystic Fibrosis: A Pilot Study. International Journal of Respiratory and Pulmonary Medicine, 2:009.
9. Semmelweis University, Department of Otorhinolaryngology and Head-Neck Surgery. Effects of salt therapy. semmelweis.hu
10. Terlizzi V, et al. (2021). Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice. Italian Journal of Pediatrics, 47(1):168. PubMed: 34362426
11. Chervinskaya AV, Zilber NA. (1995). Halotherapy for treatment of respiratory diseases. Journal of Aerosol Medicine, 8(3):221-232. PubMed: 10161255

The information in this article is for guidance only. Cystic fibrosis is a complex, lifelong condition that requires individualized treatment. Salt therapy is an adjunctive method and does not replace physician-prescribed treatments. Consult your CF center physician before starting any new therapy, including salt therapy. What works for one patient may not be suitable for another.